Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Opioid Withdrawal and Craving
NCT05511909Phase 2Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2022
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in opioid use disorder (OUD), opioid withdrawal, sponsored by University of Maryland, Baltimore. Started Dec 2022; status: recruiting.
02
Drugs
buspirone
03
Conditions
opioid use disorder (OUD)opioid withdrawal
Beyond the preview
Go deeper on NCT05511909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05511909.